{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T15:31:33Z","timestamp":1783179093985,"version":"3.54.6"},"reference-count":44,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002336","name":"Daiichi Sankyo Pharmaceutical and Kitasato-Daiichi Sankyo Vaccine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.vaccine.2018.11.045","type":"journal-article","created":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T02:33:06Z","timestamp":1543545186000},"page":"366-371","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Causal relationship between immunological responses and adverse reactions following vaccination"],"prefix":"10.1016","volume":"37","author":[{"given":"Tetsuo","family":"Nakayama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.11.045_b0005","first-page":"154","article-title":"Vaccinia virus in postvaccinal encephalitis","volume":"27","author":"Gurvich","year":"1983","journal-title":"Acta Virol"},{"key":"10.1016\/j.vaccine.2018.11.045_b0010","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.biologicals.2003.11.001","article-title":"Verification of components of acellular pertussis vaccines that have been distributed solely, been in routine use for the last two decades and contributed greatly to control of pertussis in Japan","volume":"32","author":"Kuno-Sakai","year":"2004","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2018.11.045_b0015","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s10156-013-0641-6","article-title":"Vaccine chronicle in Japan","volume":"19","author":"Nakayama","year":"2013","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.vaccine.2018.11.045_b0020","first-page":"30","article-title":"Development of a pertussis component vaccine in Japan","volume":"336","author":"Sato","year":"1990","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.vaccine.2018.11.045_b0025","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12879-015-0777-3","article-title":"Pertussis outbreak in university students and evaluation of acellular pertussis vaccine effectiveness in Japan","volume":"6","author":"Hara","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2018.11.045_b0030","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jiac.2015.05.006","article-title":"Detection of antibodies against fimbria type 3 (Fim3) is useful diagnostic assay for pertussis","volume":"21","author":"Oguchi","year":"2015","journal-title":"J Infect Chemother"},{"issue":"3","key":"10.1016\/j.vaccine.2018.11.045_b0035","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1442-200X.1996.tb03471.x","article-title":"Adverse events associated with MMR vaccines in Japan","volume":"38","author":"Kimura","year":"1996","journal-title":"Acta Paediatr Jpn"},{"key":"10.1016\/j.vaccine.2018.11.045_b0040","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0091-6749(99)70508-7","article-title":"A clinical analysis of gelatin allergy and determination of its causal relationship to the previous administration of gelatin-containing acellular pertussis vaccine combined with diphtheria and tetanus toxoids","volume":"103","author":"Nakayama","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2018.11.045_b0045","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1067\/mai.2000.108433","article-title":"Change in gelatin content of vaccines associated with reduction in reports of allergic reactions","volume":"106","author":"Nakayama","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2018.11.045_b0050","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.vaccine.2006.05.130","article-title":"Vaccine adverse events reported in post-marketing study of the Kitasato Institute from 1994 to 2004","volume":"25","author":"Nakayama","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.11.045_b0055","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2222\/jsv.55.307","article-title":"Evaluation of mouse brain-derived, inactivated Japanese encephalitis vaccine","volume":"55","author":"Kurane","year":"2005","journal-title":"Uirusu"},{"key":"10.1016\/j.vaccine.2018.11.045_b0060","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1006\/biol.2002.0345","article-title":"Development of Vero cell-derived inactivated Japanese encephalitis vaccine","volume":"30","author":"Sugawara","year":"2002","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2018.11.045_b0065","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1016\/j.vaccine.2012.04.004","article-title":"Alum-adjuvanted H5N1 whole virion inactivated vaccine (WIV) enhanced inflammatory cytokine productions","volume":"30","author":"Nakayama","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.11.045_b0070","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1016\/j.vaccine.2007.11.096","article-title":"Immunogenicity, reactogenicity, and safety of a seven-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a fully liquid DTaP-IPV-HBV-Hib combination vaccine in healthy infants","volume":"26","author":"Olivier","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.11.045_b0075","doi-asserted-by":"crossref","first-page":"677","DOI":"10.4161\/hv.27264","article-title":"Production of inflammatory cytokines in response to diphtheria-pertussis-tetanus (DPT), haemohpilus influenzae type b (Hib), and 7-valent pneumococcal (PCV7) vaccines","volume":"10","author":"Kashiwagi","year":"2014","journal-title":"Hum Vac Immunother"},{"key":"10.1016\/j.vaccine.2018.11.045_b0080","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.2169\/internalmedicine.53.3133","article-title":"Peripheral sympathetic nerve dysfunction in adolescent Japanese girls following immunization with the human papillomavirus vaccine","volume":"53","author":"Kinoshita","year":"2014","journal-title":"Intern Med"},{"key":"10.1016\/j.vaccine.2018.11.045_b0085","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.pvr.2018.02.002","article-title":"No association between HPV vaccine and reported post-vaccination symptoms in Japanese young women: results of Nagoya study","volume":"5","author":"Suzuki","year":"2018","journal-title":"Papillomavirus Res"},{"key":"10.1016\/j.vaccine.2018.11.045_b0090","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/jmv.21372","article-title":"Modified adult measles in outbreaks in Japan, 2007\u201308","volume":"81","author":"Nagai","year":"2009","journal-title":"J Med Virol"},{"issue":"62","key":"10.1016\/j.vaccine.2018.11.045_b0095","first-page":"457","article-title":"Nationwide Rubella Epidemic-Japan","volume":"2013","author":"CDC","year":"2013","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2018.11.045_b0100","first-page":"1049","article-title":"toward global measles control and regional elimination, 1990\u20131997","volume":"47","author":"Progress","year":"1998","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2018.11.045_b0105","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/0140-6736(91)91771-L","article-title":"Child mortality after high-titre measles vaccines: prospective study in Senegal","volume":"338","author":"Garenne","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2018.11.045_b0110","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(89)91967-3","article-title":"Serological effects of Edmonston-Zagreb, Schwarz and AIK-C measles vaccine strains given at ages 4\u20135 or 8\u201310 months","volume":"2","author":"Tidjiani","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2018.11.045_b0115","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1093\/ije\/23.5.1069","article-title":"Immunization of 6 and 9 month old infants with AIK-C, Edmonston-Zagreb, Leningrad-16 and Schwarz strains of measles vaccine","volume":"23","author":"Bolotovski","year":"1994","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2018.11.045_b0120","first-page":"353","article-title":"Comparison of AIK-C measles vaccine in infants at 6 months with Schwarz vaccine at 9 months: a randomized controlled trial in Ghana","volume":"76","author":"Nkrumah","year":"1998","journal-title":"Bull WHO"},{"key":"10.1016\/j.vaccine.2018.11.045_b0125","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0091-6749(95)70304-7","article-title":"IgE antibody to gelatin in children with immediate-type reactions to measles and mumps vaccines","volume":"96","author":"Sakaguchi","year":"1995","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2018.11.045_b0130","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0091-6749(96)80191-6","article-title":"Food allergy to gelatin in children with systemic immediate-type reactions, including anaphylaxis, to vaccines","volume":"98","author":"Sakaguchi","year":"1996","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2018.11.045_b0135","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1046\/j.1365-2222.2000.00940.x","article-title":"The lymphoproliferative response to enzymatically digested gelatin in subjects with gelatin hypersensitivity","volume":"30","author":"Kumagai","year":"2000","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.vaccine.2018.11.045_b0140","unstructured":"Report on the anaphylaxis following vaccination with influenza HA vaccine from The Chemo-Sero-Therapeutic Research Institute. http:\/\/www.mhlw.go.jp\/stf\/shingi\/2r9852000002c06s-att\/2r9852000002c0cb.pdf"},{"key":"10.1016\/j.vaccine.2018.11.045_b0145","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1586\/14760584.2014.933079","article-title":"Administering influenza vaccine to egg-allergic persons","volume":"13","author":"Kelso","year":"2014","journal-title":"Exp Rev Vaccines"},{"key":"10.1016\/j.vaccine.2018.11.045_b0150","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.jaci.2010.03.009","article-title":"Ovalbumin content of influenza vaccines","volume":"125","author":"Li","year":"2010","journal-title":"J Allergy Clin Immunol."},{"key":"10.1016\/j.vaccine.2018.11.045_b0155","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jaci.2015.08.001","article-title":"Highly increased levels of IgE antibodies to vaccine components in children with influenza vaccine-associated anaphylaxis","volume":"137","author":"Nagao","year":"2016","journal-title":"J Allergy Clin Immunol."},{"key":"10.1016\/j.vaccine.2018.11.045_b0160","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2147\/JIR.S34152","article-title":"Long-term persistence of IgE anti-influenza A HIN1 virus antibodies in serum of children and adults following influenza A vaccination with subsequent H1N1 infection: a case study","volume":"5","author":"Smith-Norowitz","year":"2012","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.vaccine.2018.11.045_b0165","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.jaci.2012.07.019","article-title":"Allergic symptoms after pandemic influenza vaccination rarely mediated by vaccine-specific IgE","volume":"130","author":"Rouleau","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2018.11.045_b0170","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2217\/fmb.09.108","article-title":"Innate immune evasion strategies of influenza viruses","volume":"5","author":"Hale","year":"2010","journal-title":"Future Microbiol"},{"key":"10.1016\/j.vaccine.2018.11.045_b0175","doi-asserted-by":"crossref","first-page":"6099","DOI":"10.1016\/j.vaccine.2015.05.106","article-title":"Seasonal split influenza vaccine induced IgE sensitization against influenza vaccine","volume":"33","author":"Nakayama","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.11.045_b0180","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-0320","article-title":"Febrile Seizure risk after vaccination in children 6 to 23 Months","volume":"138","author":"Duffy","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2018.11.045_b0185","doi-asserted-by":"crossref","first-page":"5815","DOI":"10.1016\/j.vaccine.2016.08.051","article-title":"An inflammatory response is essential for the development of adaptive immunity \u2013 immunogenicity and immunotoxicity","volume":"34","author":"Nakayama","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.11.045_b0190","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.vaccine.2005.06.036","article-title":"The phosphoprotein of attenuated measles AIK-C vaccine strain contributes to its temperature-sensitive phenotype","volume":"24","author":"Komase","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.11.045_b0195","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1099\/0022-1317-82-9-2143","article-title":"Leucine at position 278 of the AIK-C measles virus vaccine strain fusion protein is responsible for reduced syncytium formation","volume":"82","author":"Nakayama","year":"2001","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2018.11.045_b0200","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.vaccine.2010.11.074","article-title":"Protease and helicase domains are related to the temperature sensitivity of wild-type rubella viruses","volume":"29","author":"Sakata","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.11.045_b0205","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000299061","article-title":"Leucine at position 383 of fusion protein is responsible for fusogenicity of wild-type mumps virus in B95a cells","volume":"53","author":"Yoshida","year":"2010","journal-title":"Intervirology"},{"key":"10.1016\/j.vaccine.2018.11.045_b0210","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s40264-017-0574-6","article-title":"Suspected adverse effects after human papillomavirus vaccination: a temporal relationship between vaccine administration and the appearance of symptoms in Japan","volume":"40","author":"Ozawa","year":"2017","journal-title":"Drug Saf"},{"key":"10.1016\/j.vaccine.2018.11.045_b0215","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/1348-0421.12566","article-title":"Long-term regulation of local cytokine production following immunization in mice","volume":"62","author":"Nakayama","year":"2018","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2018.11.045_b0220","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1016\/j.vaccine.2014.04.018","article-title":"Inflammatory responses following intramuscular and subcutaneous immunization with alum-adjuvanted or non-adjuvanted vaccines","volume":"32","author":"Kashiwagi","year":"2014","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18315688?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18315688?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:30:44Z","timestamp":1759401044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18315688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0264410X18315688"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.11.045","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Causal relationship between immunological responses and adverse reactions following vaccination","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.11.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}